Just before the end of 2025, an oral version of a GLP-1 drug specifically used for weight management moved much closer to ...

NPPA fixed prices of 37 new drug formulations under DPCO 2013, covering diabetes, hypertension, respiratory and mental health ...

Learn about CJC 1295 peptide supplements that aim to reshape how men can approach muscle building, recovery, and growth ...

Corona Remedies announces commencement of capacity expansion for commercial production at Bhayla facility: Our Bureau, Mumbai Monday, December 29, 2025, 13:30 Hrs [IST] Corona Rem ...

Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcutaneous co-formulation consisting of HER2 ...

Outlook Therapeutics faces a pivotal FDA decision for Lytenava on December 31st, following two prior rejections. Read why ...

The top 10 PharmTech videos of the year cover advanced therapies, high-concentration biologics, major mergers and ...

HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has won U.S. Food and Drug Administration approval for RYBREVANT FASPRO, the ...

The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of 37 new drugs in its recent meeting, under the provisions of the Drugs Prices Control Order (DPCO), 2013, including ...

An overview of the top 10 stories from Optometry Times in 2025.

Biohaven's Phase 2 study with BHV-7000 in MDD did not meet its primary endpoint of reducing depressive symptoms in comparison ...

Strides Pharma Science Ltd's Chestnut Ridge facility received four procedural FDA observations, with no impact on supply.